Skip to main content
      Sexual Function in axSpA
      Specialized Biomarkers in PsA
      NEPTUNUS: Ianalumab in Sjogren's
      Psoriatic Arthritis Imaging

      Dr. Arthur Kavanaugh talks about imaging in psoriatic arthritis at #ACR25

      https://t.co/l6M

      Dr. John Cush RheumNow

      4 days 9 hours ago
      Psoriatic Arthritis Imaging Dr. Arthur Kavanaugh talks about imaging in psoriatic arthritis at #ACR25 https://t.co/l6MKTgEJXu https://t.co/sKhoQWCPli
      Lupus in Focus: 2025 ACR Treatment Guidelines for SLE

      Dr. Sheila Reyes reports on the scientific session presentation

      Dr. John Cush RheumNow

      4 days 11 hours ago
      Lupus in Focus: 2025 ACR Treatment Guidelines for SLE Dr. Sheila Reyes reports on the scientific session presentation of the #ACR25 treatment guidelines for SLE https://t.co/Bh1fSFf8ju https://t.co/OH8h9GDeMf
      Promising novel mechanisms of action always create excitement, but the immune checkpoint PD-1 has cemented itself in the news far more than most. This fame is primarily from therapeutic inhibition in cancer and rheumatological inflammatory sequelae that emerge, but invoking the inverse and using PD-1 agonism to treat classical autoimmunity has subsequently been making its own mark. Given the evident plausibility, how do we feel about invoking
      RheumNow’s expanded coverage of the #ACR25 meeting is sponsored by Bristol Myers Squibb, Novartis, and UCB. All covera

      Dr. John Cush RheumNow

      4 days 13 hours ago
      RheumNow’s expanded coverage of the #ACR25 meeting is sponsored by Bristol Myers Squibb, Novartis, and UCB. All coverage content is selected by RheumNow and its faculty.
      Day 1 Recap: #ACR25 Highlights

      Join RheumNow Faculty Drs. Aurelie Najm, Yuz Yusof, Janet Pope, and Jack Cush for Day 1

      Dr. John Cush RheumNow

      4 days 14 hours ago
      Day 1 Recap: #ACR25 Highlights Join RheumNow Faculty Drs. Aurelie Najm, Yuz Yusof, Janet Pope, and Jack Cush for Day 1 highlights from the 2025 ACR Convergence in Chicago, focusing on abstracts/sessions: 0775, SLE guidelines, 0163, 0832, 0776, 0792, and 0164. https://t.co/ODte4XY82a
      Ankylosing spondylitis (AS) is a burden on the bones—both literally and diagnostically. The disease’s dual nature, marked by chronic inflammation and abnormal new bone formation, complicates the assessment of bone health. While inflammation erodes trabecular bone, syndesmophytes and ligamentous calcifications can falsely elevate spine bone mineral density (BMD) readings on standard dual-energy X-ray absorptiometry (DXA).
      GLP-1 Receptor Agonists in PsA: Mortality and MACE https://t.co/GtTGHY7j5g

      @synovialjoints discussed TriNetX data bas

      Nouf Al hemmadi NoufAhmedAlham2

      4 days 15 hours ago
      GLP-1 Receptor Agonists in PsA: Mortality and MACE https://t.co/GtTGHY7j5g @synovialjoints discussed TriNetX data base looking at GLP-1 medications effect on MACE in PsA patients. @RheumNow #ACR25
      NEPTUNUS: Ianalumab in Sjogren's https://t.co/K9Xm51Kb5X

      Finally good news in Sjogrens disease.

      @RheumNow
      #ACR25

      Nouf Al hemmadi NoufAhmedAlham2

      4 days 15 hours ago
      NEPTUNUS: Ianalumab in Sjogren's https://t.co/K9Xm51Kb5X Finally good news in Sjogrens disease. @RheumNow #ACR25
      Why are vaccine Abs maintained after CAR-T
      -depletion of pathogenic #Abs are dampened/eliminated
      Clonal repetoire expan

      Janet Pope Janetbirdope

      4 days 15 hours ago
      Why are vaccine Abs maintained after CAR-T -depletion of pathogenic #Abs are dampened/eliminated Clonal repetoire expansion Remission=naive B cell pop'n Reset immune system sparing memory cells vs ?not all pathogenic cells eliminated in tissue #ACR25 @RheumNow @ACRheum #26S21 https://t.co/jb3dD5Ssip
      Day 4 Recap: ACR Convergence 2025 Highlights https://t.co/CMpbzc4O5x

      Great discussion by @EBRheum @AkhilSoodMD @Dr_B

      Nouf Al hemmadi NoufAhmedAlham2

      4 days 15 hours ago
      Day 4 Recap: ACR Convergence 2025 Highlights https://t.co/CMpbzc4O5x Great discussion by @EBRheum @AkhilSoodMD @Dr_Brian_MD . I have always been a FK fan in lupus nephritis as an add on therapy , the only inconvenience is regular monitoring. @RheumNow #ACR25
      From Fitbit to first diagnosis: AI is rewriting the RA playbook

      Two studies presented at this year’s #ACR25 meeting h

      Dr. John Cush RheumNow

      4 days 15 hours ago
      From Fitbit to first diagnosis: AI is rewriting the RA playbook Two studies presented at this year’s #ACR25 meeting highlight just how close we may be to a future where algorithms flag disease before we can and monitor activity with minimal patient burden. https://t.co/8AwBZkyZIW
      ×